FI870501A - A method for producing an antigenic cognate peptide or protein of the melanoma-associated p97 antigen, and recombinant viruses, recombinant vectors, and host cells useful therein - Google Patents

A method for producing an antigenic cognate peptide or protein of the melanoma-associated p97 antigen, and recombinant viruses, recombinant vectors, and host cells useful therein Download PDF

Info

Publication number
FI870501A
FI870501A FI870501A FI870501A FI870501A FI 870501 A FI870501 A FI 870501A FI 870501 A FI870501 A FI 870501A FI 870501 A FI870501 A FI 870501A FI 870501 A FI870501 A FI 870501A
Authority
FI
Finland
Prior art keywords
antigenic
melanoma
antigen
protein
producing
Prior art date
Application number
FI870501A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI94836C (en
FI870501A0 (en
FI94836B (en
Inventor
Joseph P Brown
Gregory D Plowman
Karl E Hellstrom
Anthony F Purchio
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Ingegerd Hellstrom
Shiu-Lok Hu
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI870501(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Publication of FI870501A0 publication Critical patent/FI870501A0/en
Publication of FI870501A publication Critical patent/FI870501A/en
Application granted granted Critical
Publication of FI94836B publication Critical patent/FI94836B/en
Publication of FI94836C publication Critical patent/FI94836C/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI870501A 1986-02-07 1987-02-06 A method for producing an antigenic cognate peptide or protein of the melanoma-associated p97 antigen, and recombinant viruses, recombinant vectors and host cells useful therein FI94836C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US82731386 1986-02-07
US723087 1987-01-27
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (4)

Publication Number Publication Date
FI870501A0 FI870501A0 (en) 1987-02-06
FI870501A true FI870501A (en) 1987-08-08
FI94836B FI94836B (en) 1995-07-31
FI94836C FI94836C (en) 1995-11-10

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870501A FI94836C (en) 1986-02-07 1987-02-06 A method for producing an antigenic cognate peptide or protein of the melanoma-associated p97 antigen, and recombinant viruses, recombinant vectors and host cells useful therein

Country Status (18)

Country Link
JP (3) JP2664673B2 (en)
BE (1) BE1000175A3 (en)
CH (1) CH675424A5 (en)
DE (1) DE3703702C2 (en)
DK (1) DK63287A (en)
ES (2) ES2012815A6 (en)
FI (1) FI94836C (en)
GR (1) GR870195B (en)
HU (1) HU209144B (en)
IE (1) IE59597B1 (en)
IT (1) IT1222359B (en)
MX (1) MX9203574A (en)
NL (1) NL8700285A (en)
NO (1) NO178931C (en)
NZ (1) NZ219192A (en)
OA (1) OA08478A (en)
PT (1) PT84255B (en)
SE (2) SE506024C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (en) * 1998-05-15 1999-11-18 Roehnisch Tim Bacteriophage expression system for production of composition for induction of tumor specific responses
JP4414023B2 (en) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 Method and reagent for measuring arthritis-related melanotransferrin
JP4708027B2 (en) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Anti-cancer compositions and anti-infective disease compositions and methods of using them
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
NZ219192A (en) 1991-10-25
IE59597B1 (en) 1994-03-09
FI94836C (en) 1995-11-10
HU209144B (en) 1994-03-28
FI870501A0 (en) 1987-02-06
DK63287D0 (en) 1987-02-06
IT1222359B (en) 1990-09-05
PT84255A (en) 1987-03-01
ES2012815A6 (en) 1990-04-16
OA08478A (en) 1988-07-29
DK63287A (en) 1987-08-08
SE9202934D0 (en) 1992-10-07
HUT43107A (en) 1987-09-28
NO870475D0 (en) 1987-02-06
SE8700466L (en) 1987-08-08
NL8700285A (en) 1987-09-01
JPH09135692A (en) 1997-05-27
IT8719291A0 (en) 1987-02-06
SE8700466D0 (en) 1987-02-06
PT84255B (en) 1989-11-30
SE506024C2 (en) 1997-11-03
JPS62294698A (en) 1987-12-22
JPH08280390A (en) 1996-10-29
NO870475L (en) 1987-08-10
JP2664673B2 (en) 1997-10-15
ES2017258A6 (en) 1991-01-16
FI94836B (en) 1995-07-31
GR870195B (en) 1987-06-10
BE1000175A3 (en) 1988-07-12
IE870319L (en) 1987-08-07
DE3703702C2 (en) 1997-07-10
CH675424A5 (en) 1990-09-28
NO178931C (en) 1996-07-03
DE3703702A1 (en) 1988-02-18
MX9203574A (en) 1992-07-01
NO178931B (en) 1996-03-25

Similar Documents

Publication Publication Date Title
AR243080A1 (en) A procedure for obtaining an immunogenic complex of proteins, antigens or peptides, with water-repelling regions and bisdesmosidic regions with water-repelling regions.
EP0433371A4 (en) Fusion protein of paramyxovirus, method of production using recombinant baculovirus expression vector, vaccine comprising such protein and use thereof
PT90312A (en) A method for the preparation of novel recombinant and chemokine antibodies directed against a human adenocarcinoma antigen
DK374087D0 (en) PROCEDURE FOR MANUFACTURING PROTEINS WITH FACTOR VIII ACTIVITY USING MICROBIAL HOUSING CELLS AND EXPRESSION VECTORS, HOST CELLS AND ANTIBODIES FOR USING THIS
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
AU6979387A (en) Fusion protein comprising influenza virus haemagglutinin and antigenic epitope
DE69434413D1 (en) FUSION PROTEINS BETWEEN ANTIGENIC AMINO ACID SEQUENCES AND BETA - 2-MICROGLOBULIN
NO885013D0 (en) PROCEDURE FOR THE MANUFACTURE OF BIODEGRADABLE MICROCAPLES OF WATER-PREPARABLE PEPTIDES AND PROTEINS, AS WELL AS MICROKA PSLS OBTAINED AT THE PROCEDURE.
DK163062C (en) ANTIGEN, IMMUNOGENE, PROTEIN CONTAINING VACCINE AGAINST COCCIDIOSE
NO882917D0 (en) FUSION PROTEINS AND PARTICLES.
NO883834D0 (en) PROCEDURE FOR THE MANUFACTURE OF NEW HIV PROTEINS AND PEPTIDES.
DK457687D0 (en) ANTIGENIC ACTIVE PROTEINS AND PEPTIDES AND VACCINES AGAINST VIRUS FOR FELIN PERITONITIS (FIPV) CONTAINING SUCH PROTEIN OR PEPTIDES
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
NO861772L (en) PROCEDURE FOR THE PREPARATION OF PROTEIN HYDROLYZATE.
FI870501A (en) A method for producing an antigenic cognate peptide or protein of the melanoma-associated p97 antigen, and recombinant viruses, recombinant vectors, and host cells useful therein
NO892269L (en) NON-HYPERGYLYCOSYLED HEPATITY B VIRUS PROTEINS AND EXPRESSION "CASSETTE" AND PROCEDURE FOR THE PREPARATION OF THE PROTEINS.
EP0293827A3 (en) Assay for leishmaniasis
DE3584029D1 (en) EXPRESSION VECTORS, DNA FRAGMENTS, PEPTIDES, HOST AND METHOD FOR PRODUCING PEPTIDES.
PT87207A (en) PROCESS FOR PREPARING RECOMBINANT HTLV-III PROTEINS AND USES THEREOF
ZA874677B (en) Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same
NO178036C (en) Process for Preparation of Fusion Proteins, Gene Structure, Vectors of Streptomycet Cells and the Fusion Proteins
DE3877136D1 (en) RECOMBINANT HISTIDINE PROTEIN OF PLASMODIUM FALCIPARUM, ITS PRODUCTION AND USE.
AU596692B2 (en) DNA coding for antigen protein of rinderpest virus
DK116487A (en) PROCEDURE FOR EXPOSURE OF AN EPITOP IN A PROTEIN WITH SPECIFIC POLYPEPTIME STRUCTURE, AND VECTORS FOR USING THE PROCEDURE, HYBRID PROTEINS INCLUDING THE EPITOPE AND USE OF THE HYBRID PROTEIN PROTEIN.
AP9300556A0 (en) Peptides,analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: ONCOGEN